LifeStance Health Gr Analyst Ratings
LifeStance Health Gr Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
07/13/2023 | 14.68% | Morgan Stanley | $10 → $10 | Reiterates | Overweight → Overweight |
05/19/2023 | 3.21% | Goldman Sachs | $8 → $9 | Maintains | Neutral |
05/11/2023 | 14.68% | Morgan Stanley | $8 → $10 | Maintains | Overweight |
01/06/2023 | -8.26% | Morgan Stanley | → $8 | Upgrades | Equal-Weight → Overweight |
11/15/2022 | -8.26% | Goldman Sachs | $9 → $8 | Maintains | Neutral |
11/14/2022 | -8.26% | Cowen & Co. | $10 → $8 | Maintains | Outperform |
11/07/2022 | — | Jefferies | Assumes | → Buy | |
08/22/2022 | 14.68% | Cowen & Co. | $11 → $10 | Maintains | Outperform |
05/10/2022 | -8.26% | Morgan Stanley | $10 → $8 | Maintains | Equal-Weight |
03/21/2022 | 14.68% | Goldman Sachs | $15 → $10 | Maintains | Neutral |
03/17/2022 | 14.68% | UBS | $19 → $10 | Downgrades | Buy → Neutral |
12/17/2021 | 14.68% | Morgan Stanley | $15 → $10 | Maintains | Equal-Weight |
11/09/2021 | 37.61% | JP Morgan | $24 → $12 | Downgrades | Overweight → Neutral |
09/10/2021 | 106.42% | Cowen & Co. | → $18 | Initiates Coverage On | → Outperform |
08/16/2021 | 83.49% | Morgan Stanley | $36 → $16 | Downgrades | Overweight → Equal-Weight |
07/06/2021 | 289.91% | UBS | → $34 | Initiates Coverage On | → Buy |
07/06/2021 | — | William Blair | Initiates Coverage On | → Outperform | |
07/06/2021 | 312.84% | Morgan Stanley | → $36 | Initiates Coverage On | → Overweight |
07/06/2021 | 312.84% | JP Morgan | → $36 | Initiates Coverage On | → Overweight |
07/06/2021 | 186.7% | Goldman Sachs | → $25 | Initiates Coverage On | → Neutral |
日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变化 | 上一页/当前额定值 |
---|---|---|---|---|---|
07/13/2023 | 14.68% | 摩根士丹利 | 10 美元 → 10 美元 | 重申 | 超重 → 超重 |
05/19/2023 | 3.21% | 高盛 | 8 美元 → 9 美元 | 维护 | 中立 |
05/11/2023 | 14.68% | 摩根士丹利 | 8 美元 → 10 美元 | 维护 | 超重 |
01/06/2023 | -8.26% | 摩根士丹利 | → 8 美元 | 升级 | 重量相等 → 超重 |
11/15/2022 | -8.26% | 高盛 | 9 美元 → 8 美元 | 维护 | 中立 |
11/14/2022 | -8.26% | Cowen & Co. | 10 美元 → 8 美元 | 维护 | 跑赢大盘 |
2022 年 7 月 11 日 | — | 杰富瑞 | 假设 | → 购买 | |
08/22/2022 | 14.68% | Cowen & Co. | 11 美元 → 10 美元 | 维护 | 跑赢大盘 |
05/10/2022 | -8.26% | 摩根士丹利 | 10 美元 → 8 美元 | 维护 | 重量相等 |
03/21/2022 | 14.68% | 高盛 | 15 美元 → 10 美元 | 维护 | 中立 |
03/17/2022 | 14.68% | 瑞银(UBS) | 19 美元 → 10 美元 | 降级 | 买入 → 中性 |
12/17/2021 | 14.68% | 摩根士丹利 | 15 美元 → 10 美元 | 维护 | 重量相等 |
2021 年 9 月 11 日 | 37.61% | 摩根大通 | 24 美元 → 12 美元 | 降级 | 超重 → 中性 |
2021 年 10 月 9 日 | 106.42% | Cowen & Co. | → 18 美元 | 开启覆盖范围 | → 跑赢大盘 |
2021 年 8 月 16 日 | 83.49% | 摩根士丹利 | 36 美元 → 16 美元 | 降级 | 超重 → 重量相等 |
2021 年 6 月 7 日 | 289.91% | 瑞银(UBS) | → 34 美元 | 开启覆盖范围 | → 购买 |
2021 年 6 月 7 日 | — | 威廉布莱尔 | 开启覆盖范围 | → 跑赢大盘 | |
2021 年 6 月 7 日 | 312.84% | 摩根士丹利 | → 36 美元 | 开启覆盖范围 | → 超重 |
2021 年 6 月 7 日 | 312.84% | 摩根大通 | → 36 美元 | 开启覆盖范围 | → 超重 |
2021 年 6 月 7 日 | 186.7% | 高盛 | → 25 美元 | 开启覆盖范围 | → 中立 |
What is the target price for LifeStance Health Gr (LFST)?
LifeStance Health Gr (LFST) 的目标价格是多少?
The latest price target for LifeStance Health Gr (NASDAQ: LFST) was reported by Morgan Stanley on July 13, 2023. The analyst firm set a price target for $10.00 expecting LFST to rise to within 12 months (a possible 14.68% upside). 8 analyst firms have reported ratings in the last year.
摩根士丹利于2023年7月13日公布了LifeStance Health Gr(纳斯达克股票代码:LFST)的最新目标股价。这家分析公司将目标股价定为10.00美元,预计LFST将在12个月内升至10.00美元(可能上涨14.68%)。去年有8家分析公司公布了评级。
What is the most recent analyst rating for LifeStance Health Gr (LFST)?
分析师对LifeStance Health Gr(LFST)的最新评级是多少?
The latest analyst rating for LifeStance Health Gr (NASDAQ: LFST) was provided by Morgan Stanley, and LifeStance Health Gr reiterated their overweight rating.
LifeStance Health Gr(纳斯达克股票代码:LFST)的最新分析师评级由摩根士丹利提供,LifeStance Health Gr重申了其增持评级。
When is the next analyst rating going to be posted or updated for LifeStance Health Gr (LFST)?
LifeStance Health Gr(LFST)的下一个分析师评级何时公布或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of LifeStance Health Gr, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for LifeStance Health Gr was filed on July 13, 2023 so you should expect the next rating to be made available sometime around July 13, 2024.
分析师在进行了广泛的研究,包括浏览公开财务报表、与LifeStance Health Gr的高管和客户交谈以及听取财报电话会议后得出股票评级。大多数分析师每三个月进行一次评级,因此每家公司每年应该获得4个评级。LifeStance Health Gr的最后一次评级是在2023年7月13日提交的,因此你应该预计下一个评级将在2024年7月13日左右公布。
Is the Analyst Rating LifeStance Health Gr (LFST) correct?
分析师对 LifeStance Health Gr (LFST) 的评级正确吗?
While ratings are subjective and will change, the latest LifeStance Health Gr (LFST) rating was a reiterated with a price target of $10.00 to $10.00. The current price LifeStance Health Gr (LFST) is trading at is $8.72, which is out of the analyst's predicted range.
虽然评级是主观的,会发生变化,但最新的LifeStance Health Gr(LFST)评级得到了重申,目标股价为10.00美元至10.00美元。LifeStance Health Gr(LFST)目前的交易价格为8.72美元,超出了分析师的预测区间。